Moderna Inc. has announced that its Chief Legal Officer and Secretary, Shannon Thyme Klinger, will retire from her role effective March 31, 2024. In recognition of her service to the Massachusetts-based biotechnology company, Klinger will receive a severance package totaling $1.6 million. Her departure marks a significant moment for Moderna as it continues to navigate the complexities of the pharmaceutical industry during a time of growth and innovation. For more details, you can read the announcement here.
Klinger has been a pivotal figure at Moderna, where she played a crucial role in guiding legal and regulatory strategies. Her contributions have been instrumental in Moderna’s rapid expansion and successful distribution of its COVID-19 vaccine, which has become a cornerstone of the company’s business.
In addition to her severance, Klinger’s decision to retire is part of a broader strategy for the company as it assesses its long-term leadership structure. Moderna has been positioning itself for sustained growth, and ensuring continuity in its legal operations is pivotal.
Klinger joined Moderna in June 2021, and prior to her tenure there, she held significant legal roles at Sandoz, a division of Novartis, where she gained extensive experience in navigating the complex regulatory landscape of the pharmaceutical sector. Her background in life sciences legal matters positioned her well to handle Moderna’s legal challenges during her tenure at the company.
Moderna has yet to announce Klinger’s successor, but it is anticipated that the company will look for a candidate who can continue to support its ambitious growth trajectory while managing the evolving legal challenges associated with vaccine development and delivery.